Research led by Professors Jianxing He and Wenhua Liang from the First Affiliated Hospital of Guangzhou Medical University ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

In 2015, the First Affiliated Hospital of Guangzhou Medical University, in collaboration with the Guangdong Hetaoxiang ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

About Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma The global incidence ... engineered to deliver Actinium-225 (225 Ac) to solid tumors expressing 5T4. This oncofetal protein ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...